Join Now

Author Archives: Press Release

PolarityTE Reports Fiscal Year 2021 Financial Results and Provides Business Update

By Press Release | Published March 31, 2022

SALT LAKE CITY, March 30, 2022 /PRNewswire/ — PolarityTE, Inc. (Nasdaq: PTE) a biotechnology company developing regenerative tissue products and biomaterials, today provided a business update and reported financial results for the twelve-month period ended December 31, 2021. Recent Business and Financial Updates In the first quarter of 2022, PolarityTE received approval from the U.S. […]

Posted in BioUtah News | Tagged | Leave a comment

Altitude Lab Announces First Cohort of Startups Close Over $50M in Seed Capital

By Press Release | Published March 31, 2022

The total capital represents the largest seed financing for life science startups in Utah’s history

Posted in BioUtah News | Tagged | Leave a comment

Halia Therapeutics Presented Data on Targeting the NLRP3 Inflammasome for the Treatment of Alzheimer’s Disease

By Press Release | Published March 31, 2022

Halia Therapeutics presented data today on its NLRP3 inhibitor program at today’s 10th Annual Neurodegenerative Drug Development Summit. 

Posted in BioUtah News | Tagged | Leave a comment

Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2022

By Press Release | Published March 31, 2022

Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2022

Posted in BioUtah News | Tagged | Leave a comment

Pfizer’s $7B bet delivers phase 3 success, advancing bid to establish new drug in ulcerative colitis Arena

By Press Release | Published March 24, 2022

Pfizer’s $6.7 billion bet on Arena Pharmaceuticals has delivered a phase 3 success.

Posted in BioUtah News | Tagged | Leave a comment

Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2021 Financial Results

By Press Release | Published March 24, 2022

Recursion reported business updates and financial results for its fourth quarter and fiscal year ending December 31, 2021.

Posted in BioUtah News | Tagged | Leave a comment

FierceBiotech recognizes Recursion as the #2 Biotech IPO of 2021!

By Press Release | Published March 24, 2022

FierceBiotech Special Report: The top 10 biotech IPOs of 2021

Posted in BioUtah News | Tagged | Leave a comment

Co-Diagnostics Reports Full Year 2021 Financial Results

By Press Release | Published March 24, 2022

Achieved Record Full Year Revenue of $97.9 Million; Strength in Sales Momentum Provides Foundation to Achieve Solid FY’22

Posted in BioUtah News | Tagged , | Leave a comment

Co-Diagnostics, Inc. Makes Strategic Additions to Scientific Advisory Board

By Press Release | Published March 17, 2022

Co-Diagnostics, Inc. Makes Strategic Additions to Scientific Advisory Board

Posted in BioUtah News | Tagged , | Leave a comment

Myriad Genetics Named to Fast Company’s Annual List of World’s Most Innovative Companies

By Press Release | Published March 17, 2022

Myriad to establish new Walter Gilbert Research and Innovation Center Company also cited among 2022 Top Workplaces USA National List by Energage

Posted in BioUtah News | Tagged | Leave a comment

Myriad Genetics Receives FDA Approval of BRACAnalysis® CDx as a Companion Diagnostic for Lynparza® in Early Breast Cancer

By Press Release | Published March 17, 2022

BRACAnalysis CDx is now the only germline test approved by FDA as a companion diagnostic for treatment of HER2 negative high-risk early-stage breast cancer

Posted in BioUtah News | Tagged | Leave a comment

Myriad Genetics Advances Precision Oncology with New Precise™ Solutions, Combines Genetic Insights from Multiple Tests to Guide Treatment Decisions and Improve Patient Care

By Press Release | Published March 17, 2022

Company launches Precise™ Tumor test, part of a comprehensive suite combining germline, tumor and companion diagnostics in one easy-to-access solution

Posted in BioUtah News | Tagged | Leave a comment

A Special Thanks To Our Elite Members